{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:07Z","timestamp":1783488307022,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10689-021-00282-w","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T10:06:34Z","timestamp":1634897194000},"page":"473-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Medullary thyroid cancer and pheochromocytoma in MEN2A: are there parent of origin effects on disease expression?"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-079X","authenticated-orcid":false,"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1399-0004.2011.01790.x","volume":"81","author":"A Guilmatre","year":"2012","unstructured":"Guilmatre A, Sharp AJ (2012) Parent of origin effects. Clin Genet 81:201\u2013209","journal-title":"Clin Genet"},{"key":"282_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"Mucha L, Leidig-Bruckner G, Frank-Raue K, Bruckner T, Kroiss M, Raue F, German study group for rare thyroid cancer (2017) Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin Endocrinol 87:320\u2013326","journal-title":"Clin Endocrinol"},{"key":"282_CR3","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L, Chabre O, Boneu A, Caron J, Houdent C, Modigliani E, Rohmer V, Schlumberger M, Eng C, Guillausseau PJ, Lenoir GM (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe d\u2019Etude des Tumeurs \u00e0 Calcitonine. J Clin Endocrinol Metab 83:487\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"282_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567\u2013610","journal-title":"Thyroid"},{"key":"282_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H, European Multiple Endocrine Neoplasia (EUROMEN) Study Group (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517\u20131525","journal-title":"N Engl J Med"},{"key":"282_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.23430","volume":"39","author":"A Machens","year":"2018","unstructured":"Machens A, Lorenz K, Weber F, Dralle H (2018) Genotype-specific progression of hereditary medullary thyroid cancer. Hum Mutat 39:860\u2013869","journal-title":"Hum Mutat"},{"key":"282_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12020-020-02232-5","volume":"68","author":"A Machens","year":"2020","unstructured":"Machens A, Elwerr M, Lorenz K, Weber F, Dralle H (2020) 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A. Endocrine 68:368\u2013376","journal-title":"Endocrine"},{"key":"282_CR8","first-page":"233","volume":"60","author":"I Schuffenecker","year":"1997","unstructured":"Schuffenecker I, Ginet N, Goldgar D, Eng C, Chambe B, Boneu A, Houdent C, Pallo D, Schlumberger M, Thivolet C, Lenoir GM (1997) Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d\u2019Etude des Tumeurs a Calcitonine. Am J Hum Genet 60:233\u2013237","journal-title":"Am J Hum Genet"},{"key":"282_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/1055-9965.EPI-16-0182","volume":"25","author":"JR Vos","year":"2016","unstructured":"Vos JR, Oosterwijk JC, Aalfs CM, Rookus MA, Adank MA, van der Hout AH, van Asperen CJ, G\u00f3mez Garcia EB, Mensenkamp AR, Jager A, Ausems MG, Mourits MJ, de Bock GH, Hereditary Breast and Ovarian Cancer Research Group Netherlands (2016) Bias explains most of the parent-of-origin effect on breast cancer risk in BRCA1\/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 25:1251\u20131258","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"282_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10689-020-00167-4","volume":"19","author":"SD Gemechu","year":"2020","unstructured":"Gemechu SD, van Vliet CM, Win AK, Figueiredo JC, Le Marchand L, Gallinger S, Newcomb PA, Hopper JL, Lindor NM, Jenkins MA, Dowty JG (2020) Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation? Fam Cancer 19:215\u2013222","journal-title":"Fam Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00282-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00282-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00282-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T10:54:37Z","timestamp":1667559277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00282-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00282-w","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Retrospective analysis of existing data sets from routine patient care does not require institutional review board approval under national law and applicable institutional regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All carriers underwent DNA-based screening and standard operations for MEN2A-associated tumors after informed consent according to applicable diagnostic and therapeutic standards (routine patient care).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (aggregate data only, no patient level data).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}